This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Diaz-Mitoma, F.
Right arrow Articles by Caissie, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Diaz-Mitoma, F.
Right arrow Articles by Caissie, G.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, 03 1996, 657-663, Vol 34, No. 3
Copyright © 1996 by the American Society for Microbiology. All rights reserved.

Detection of viral DNA to evaluate outcome of antiviral treatment of patients with recurrent genital herpes

F Diaz-Mitoma, M Ruben, S Sacks, P MacPherson and G Caissie
Division of Virology, Department of Laboratory Medicine, Children's Hospital of Eastern Ontario, Ottawa, Canada.

Culture of infectious virus, PCR amplification of viral DNA, and the appearance of genital skin lesions were used as markers to study the course of a recurrence of genital herpes in 40 patients treated with famciclovir or placebo. The highest frequency of patients with skin lesions occurred within the first 36 h following the onset of a recurrence, which also corresponded to the peak in the production of virus. While the timing of the peak in skin lesions was independent of the type of treatment, the frequency of lesions and the release of virus at the lesion site were both reduced by famciclovir treatment. Furthermore, patients receiving this antiviral agent showed a more rapid recovery time and a shorter period during which viral DNA could be detected at the lesion. PCR and then Southern blot hybridization greatly enhanced our ability to detect herpes simplex virus at the lesion site. This procedure proved to be of greater diagnostic value in assessing genital herpes than the standard culture method currently used. In addition, PCR was more sensitive in evaluating treatment effectiveness.


This article has been cited by other articles:

  • Fife, K. H., Warren, T. J., Ferrera, R. D., Young, D. G., Justus, S. E., Heitman, C. K., Burroughs, S. M. (2006). Effect of Valacyclovir on Viral Shedding in Immunocompetent Patients With Recurrent Herpes Simplex Virus 2 Genital Herpes: A US-Based Randomized, Double-Blind, Placebo-Controlled Clinical Trial. Mayo Clin Proc. 81: 1321-1327 [Abstract] [Full Text]  
  • do Nascimento, M. C., Sumita, L. M., de Souza, V. A. U. F., Pannuti, C. S. (1998). Detection and Direct Typing of Herpes Simplex Virus in Perianal Ulcers of Patients with AIDS by PCR. J. Clin. Microbiol. 36: 848-849 [Abstract] [Full Text]